A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
Jennifer L PhillipsNatalia JaworskaElizabeth KamlerVenkat BhatJean BlierJane A FosterStefanie HasselKeith HoLisa McMurrayRoumen MilevZahra MoazamigoudarziFranca M PlacenzaStéphane Richard-DevantoySusan RotzingerGustavo TureckiGustavo H VazquezSidney H KennedyPierre Bliernull nullPublished in: BMC psychiatry (2020)
ClinicalTrials.gov identifier NCT03674671. Registered September 17, 2018.